Functional brain imaging and aging in schizophrenia

Schizophrenia Research

Volumn 27, Issue 2-3, 1997, Pages 129-141

  Buchsbaum, Monte S ^a   Hazlett, Erin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral blood flow; Cerebral glucose metabolic rate; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGING; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN METABOLISM; CONFERENCE PAPER; FEMALE; FRONTAL LOBE; GLUCOSE METABOLISM; HUMAN; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGING; BASAL GANGLIA; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030782058     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00076-5     Document Type: Conference Paper

References (51)

1. Andreasen, N.C., Flaum, M., Arndt, S., 1992. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49, 615-623.
2. Arndt, S., Andreasen, N.C., Flaum, M. et al., 1995. A longitudinal study of symptom dimensions in schizophrenia. Arch. Gen. Psychiatry 52, 352-360.
3. Buchsbaum, M., Hazlett, E., in press. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr. Bull.
4. Buchsbaum, M.S., Nuechterlein, K.H., Haier, R.J. et al., 1990. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br. J. Psychiatry 156, 216-227.
5. Castle, D.J., Wessely, S., Murray, R.M., 1993. Sex and schizophrenia: effects of diagnostic stringency, and associations with premorbid variables. Br. J. Psychiatry 162, 658-664.
6. Chawluk, J.B., Alavi, A., Dann, R. et al., 1987. Positron emission tomography in aging and dementia: effect of cerebral atrophy. J. Nucl. Med. 28, 431-437.
7. Creasey, H., Rapoport S.I., 1985. The aging human brain. Ann. Neurol. 17, 2-10.
8. de Leon, M.J., George, A.E., Ferris, S.H. et al., 1984. Positron emission tomography and computed tomography assessments of the aging human brain. J. Comput. Assisted Tomography 8, 88-94.
9. Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., 1987. California Verbal Learning Test Manual. Harcourt Brace Jovanovich, San Antonio, TX.
10. DeLisi, L.E., 1997. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr. Res. 23, 119-129.
11. DeLisi, L.E., Sakuma, M., Tew, W. et al., 1997. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. Neuroimaging 74, 129-139.
12. De Santi, S., de Leon, M.J., Convit, A. et al., 1995. Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr. Q. 66, 357-370.
13. Duara, R., Margolin, R.A., Robertson-Tchabo, E.A. et al., 1983. Cerebral glucose metabolism, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain 106, 761-775.
14. Eaton, W.W., Mortensen, P.B., Herrman, H. et al., 1992. Long-term course of hospitalization for schizophrenia: part I. Risk for rehospitalization. Schizophr. Bull. 18, 217-228.
15. Fenton, W.S., McGlashan, T.H., 1994. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry 151, 351-356.
16. Goldman-Rakic, P.S., Selemon, L.D. 1986. Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In: Jones, E.G., Peters, A. (Eds.), Cerebral Cortex, vol. 2: Physiology. Plenum Press, New York.
17. Gur, R.C., Gur, R.E., Obrist, W.D. et al., 1987. Age and regional cerebral blood flow at rest and during cognitive activity. Arch. Gen. Psychiatry 44, 617-621.
18. Jeste, D.V., Lohr, J.B., Mani, R.B. et al., 1986. Neuronal loss in normal aging and neuropsychiatric dementias. In: Jeste, D.V. (Ed.), Neuropsychiatric Dementias. American Psychiatric Press, Washington, DC.
19. Kraepelin, E., 1899. Ein Lehrbuch für Studirende und Aerzte, vol. II. Verlagvon, Barth, Leipzig.
20. Kraepelin, E., 1919. Dementia Praecox and Paraphrenia (R.M. Barclay, Trans., 1971). Krieger, New York.
21. Kuhl, D.E., Metter, J., Riege, W.H., Phelps, M.E., 1982. Effects of human aging on patterns of local cerebral glucose utilization determined by the 18-F-fluorodeoxyglucose method. J. Cereb. Blood Flow Metab. 2, 163-171.
22. Leenders, K.L., Perani, D., Lammertsma, A.A. et al., 1990. Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain 113, 27-47.
23. Lewine, R.R.J., 1988. Gender and schizophrenia. In: Nasrallah, H.A. (Ed.), Handbook of Schizophrenia, vol. 3. Elsevier, Amsterdam, pp. 379-397.
24. Liddle, P.F., 1987. Three syndromes of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br. J. Psychiatry 151, 145-151.
25. Liddle, P.F., Friston, K.J., Frith, C.D. et al., 1992. Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry 160, 179-186.
26. Loessner, A., Alavi, A., Lewandrowski, K.U. et al., 1995. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J. Nucl. Med. 36, 1141-1149.
27. Marchal, G., Rioux, P., Petit-Taboué, M. et al., 1992. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging. Arch. Neurol. 49, 1013-1020.
28. Martin, A.J., Friston, K.J., Colebatch, J.G., Frackowiak, R.S.J., 1991. Decreases in regional cerebral blood flow with normal aging. J. Cereb. Blood Flow Metab. 11, 684-689.
29. McGlashan, T.H., 1988. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr. Bull. 14, 515-542.
30. Melamed, E., Lavy, S., Bentin, S. et al., 1980. Reduction in regional cerebral blood flow during normal aging in man. Stroke 11, 31-35.
31. Moeller, J.R., Ishikawa, T., Dhawan, V. et al., 1996. The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 16, 385-398.
32. Murphy, D.G.M., DeCarli, C., McIntosh, A.R. et al., 1996. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch. Gen. Psychiatry 53, 585-594.
33. Pantano, P., Baron, J., Lebrun-Grandié, P. et al., 1984. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 15, 635-641.
34. Pogue-Geile, M.F., Harrow, M., 1985. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr. Bull. 11, 427-439.
35. Poline, J.-B., Mazoyer, B.M., 1993. Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters. J. Cereb. Blood Flow Metab. 13, 425-437.
36. Poon, L.W., 1985. Differences in human memory with aging: nature, causes, and clinical implications. In: Birren, J., Schaie, K.W. (Eds.), Handbook of the Psychology of Aging. Van Nostrand Reinhold, New York, pp. 427-462.
37. Riege, W.H., Metter, E.J., Kuhl, D.E. et al., 1985. Brain glucose metabolism and memory functions: age decrease in factor scores. J. Gerontol. 40, 459-467.
38. 15O-butanol brain activation images. Hum. Brain Mapp. 1, 3-19.
39. Salmon, E., Maquet, P., Sadzot, B. et al., 1991. Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. Acta Neurol. Belg. 91, 288-295.
40. Schröder, J., Buchsbaum, M.S., Siegel, V.V. et al., 1994. Patterns of cortical activation in schizophrenia. Psychol. Med. 24, 947-955.
41. Schröder, J., Buchsbaum, M.S., Siegel, B.V. et al., 1996. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr. Res. 19, 41-53.
42. Shihabuddin, L., Buchsbaum, M.S., Davis, K. et al., 1996. Ventricles enlarge in Kraepelinian schizophrenics. Proceedings of the Xth World Congress of Biological Psychiatry, Madrid, Spain, 23-28 August.
43. Shihabuddin, L., Buchsbaum, M.S., Hazlett, E.A. et al., in press. Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Arch. Gen. Psychiatry.
44. Siegel, B.V., Reynolds, C., Lohr, J.B. et al., 1994. Changes in regional cerebral metabolic rate with age in schizophrenics and normal adults. Dev. Brain Dysfunct. 7, 132-146.
45. Stuss, D.T., Benson, D.F., 1986. The Frontal Lobes. Raven Press, New York.
46. Takada, H., Nagata, K., Hirata, Y. et al., 1992. Age-related decline of cerebral oxygen metabolism in normal population detected with positron emission tomography. Neurol. Res. 14, 128-131.
47. Talairach, J., Tournoux, P., 1988. Co-planar Stereotaxic Atlas of the Human Brain. Three-dimensional Proportional System: An Approach to Cerebral Imaging (M. Rayport, Trans.). Thieme Medical, New York.
48. Tempel, L.W., Perlmutter, J.S., 1992. Vibration-induced regional cerebral blood flow responses in normal aging. J. Cereb. Blood Flow Metab. 12, 554-561.
49. Waddington, J.L., Scully, P.J., Youssef, H.A., 1997. Developmental trajectory and disease progression in schizophrenia: the conundrum, and insights from a 12-year prospective study in the Monaghan 101. Schizophr. Res. 23, 107-118.
50. Wang, G.J., Volkow, N.D., Roque, C.T. et al., 1993. Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 186, 59-65.
51. Yoshii, F., Barker, W.W., Chang, J.Y. et al., 1988. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J. Cereb. Blood Flow Metab. 8, 654-661.